April 1, 2019
Titan with enough to fund planned operations through the third quarter of 2019, Probuphine well-positioned for global success
Titan’s President and CEO, Sunil Bhonsle said that the second half of 2018 as the company’s rapid advancement toward becoming a commercial-stage company following its assumption of responsibility for Probuphine sales in the U.S. starting mid-June.